WORLDREMIT
18.12.2020 10:02:12 CET | Business Wire | Press release
Today, WorldRemit , a leading cross-border payments company, celebrates International Migrants Day by announcing its list of the top 20 Migrant Moments of 2020. This list features developments which have had significant impacts on communities across the world. From the first COVID-19 vaccine to the US presidential election to SpaceX - each of these milestones have been influenced by migrants from around the world. 2020 marks the 20th anniversary of International Migrants Day and the 30th anniversary since the adoption by the UN General Assembly of the International Convention on the Protection of All Migrant Workers and Members of their Families1 .
WorldRemit has compiled this list to bring attention to all those who have managed to make a positive difference during this exceptionally challenging year. The company aims to support migrant communities as well as their family and friends every day, whilst celebrating their many successes throughout the year, and for many years to come.
The 2020 list includes:
- COVID-19 Vaccine: German couple of Turkish descent, husband and wife Uğur Şahin and Özlem Türeci, have been credited with the discovery of the Pfizer/BioNTech Covid-19 vaccine that is being distributed across the globe.
- Senator Kamala Harris: Kamala Harris became vice-president elect following the 2020 US Presidential election. In 2017, she was sworn in as a United States Senator for California, becoming the second African-American woman and first South-Asian American senator in history. Though she was born in Oakland, California, Harris’ parents emigrated to the United States from India and Jamaica.
- Future Stars: WorldRemit and Arsenal Football Club welcomed the winners of the Future Stars competition to London in January. Chinasa Mandy Ukandu of Nigeria and Luis Alejandro Castañeda from Colombia, won an all expenses paid trip to London to take part in a personalized training program with Arsenal Football Club’s Development coaches.
- Zoom boom: Zoom, the videoconferencing platform which has allowed friends, families and colleagues to stay in touch during Covid-19, was founded by Eric Yuan, a Chinese migrant to the United States. At its peak, the firm counted more than 300 million daily participants in virtual meetings, while paying customers have more than tripled.
- Project 8000: WorldRemit was the main sponsor of the Project 8000 programme in Singapore. Project 8000 is a community outreach initiative to give thousands of handwritten ‘thank you’ cards to frontline Covid-19 healthcare workers at the Tan Tock Seng Hospital (TTSH) in Singapore, led by student Marion Lee.
- Deliveroo and DoorDash: DoorDash, America’s most popular meal delivery app, was started by a Chinese American migrant, Tony Xu. Meanwhile Deliveroo was co-founded by William Shu, a Taiwanese American entrepreneur. DoorDash has launched a number of initiatives during the pandemic. In October, it launched the Reopen for Delivery campaign, with the stated aim of bringing together brick and mortar restaurants that have closed due to the pandemic.
- Patoranking: WorldRemit signed Patoranking as the Global Brand Ambassador for its Africa-focused WorldRemit Entrepreneurs Program. The WorldRemit Entrepreneurs Program will run simultaneously in Nigeria, Ghana, Kenya, and Zimbabwe, from November 2020 through to the end of January 2021. WorldRemit customers from around the world are encouraged to send a minimum of £50 (or its equivalent value in their local currency) to recipients in Nigeria, Ghana, Kenya, or Zimbabwe to win the opportunity to nominate a lucky entrepreneur.
- WorldRemit celebrated Philippine Independence Day by highlighting the many achievements of the Filipino diaspora which included one of the youngest ever recipients of the Royal Bank of Canada’s Top 25 Canadian Immigrant Award.
- Transfer Tracker app: WorldRemit launched The WorldRemit Transfer Tracker mobile app for recipients of money transfers, which allows them to track their remittances. The WorldRemit Transfer Tracker App is now available through the Google app store and is also free to download through the app store in 90 countries in iOS and Android.
- SpaceX Dragon 2: The spacecraft made its first crewed flight to the International Space Station on May 31, 2020 as part of the Commercial Crew Program, enabling American human orbital spaceflight capability for the first time since the Space Shuttle's retirement in 2011.
- Television Commercial: WorldRemit released global television commercials across key markets to promote its transparent pricing strategy and the opportunities created by connecting people through international money transfers.
- NHS workers: Almost 1 in 17 (14%) of the NHS’s 1.28 million staff report a non-British nationality, amounting to approximately 170,000 key workers. India is responsible for the most NHS workers from outside the UK, followed by the Philippines.
- Earlier this year, WorldRemit gave away £400,000 worth of vouchers to NHS workers as a token of appreciation for their service and the sacrifices they are making throughout the pandemic.
- Edward Enninful and Misan Harriman: Edward Enninful is the Editor-In-Chief of British Vogue and an advocate for better representation in the fashion industry. He is the only black editor in history to lead Vogue magazine. Enninful commissioned black photographer Misan Harriman to shoot Vogue’s UK September issue – traditionally the magazine’s most important edition. As well as being one of the most widely-shared photographers of the Black Lives Matter movement, Harriman is the first black person to shoot a cover of British Vogue in the magazine's 104-year history.
- Netflix launches Selena series: Netflix released its biographical drama that follows Selena Quintanilla Lopez’s rise to fame and the sacrifices she and her family make along the way charting her enduring legacy as a Mexican-American icon.
- David Olusoga: David Olusoga is a British-Nigerian historian and writer. In response to the Black Lives Matter movement, Olusoga's Black and British: A Forgotten History was broadcast on the BBC. The documentary was awarded a BAFTA when originally produced in 2016. Olusoga was also named on the 2021 Powerlist.
- Parasite: Parasite, a film written by South Korean native Bong Joon-ho, became the first non-English language film to win the Oscar for Best Picture in the 92-year history of the awards.
- Adewale Adeyemo: Among Biden’s team of top cabinet picks and economic advisers is Nigerian-born Adewale Adeyemo, who served as a senior international economic adviser in the Barack Obama administration. Adeyemo will be the first African to occupy the seat of Deputy Treasury Secretary.
- As part of efforts to create opportunities for those in developing countries, WorldRemit gave away tablets to students in countries including India and Guatemala following the pandemic-related disruption to schooling.
- A 90-year old lady named Margaret Keenan from Coventry, became the first person in the world to receive the Pfizer & BioNTech COVID-19 vaccine, which was administered by Filipina nurse May Parsons.
To learn more about WorldRemit, please visit www.worldremit.com .
WorldRemit
WorldRemit is a leading global payments company. We disrupted an industry previously dominated by offline legacy players by taking international money transfers online - making them safer, faster and lower-cost. We currently send from 50 to 150 countries, operate in more than 5,000 money transfer corridors worldwide and employ over 1,200 people globally.
On the sending side WorldRemit is 100% digital (cashless), increasing convenience and enhancing security. For those receiving money, the company offers a wide range of options including bank deposit, cash collection, mobile airtime top-up and mobile money.
Backed by Accel, TCV and Leapfrog – WorldRemit’s headquarters are in London, United Kingdom with regional offices in the United States, Canada, Australia, New Zealand, Hong Kong, Singapore, Malaysia, the Philippines, South Africa, Somaliland, Uganda, Kenya, Rwanda, Tanzania, Zimbabwe and Belgium.
________________
1
https://sdg.iisd.org/events/international-migrants-day-2020/
View source version on businesswire.com: https://www.businesswire.com/news/home/20201218005131/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Acceleronix, IDEMIA Secure Transactions and Orange Announce Flexible, Single-SKU Manufacturing with Quantum-Safe IFPP4.11.2026 16:44:00 CET | Press release
One SKU. Every market. Connectivity decided at the end of production. Live at electronica 2026. Orange, one of the world’s leading telecom operators, has joined the global quantum-safe In-Factory Profile Provisioning (IFPP) program, jointly launched by Acceleronix and IDEMIA Secure Transactions at MWC Barcelona in February. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104070181/en/ Acceleronix, IDEMIA Secure Transactions and Orange announce flexible, single-SKU manufacturing with quantum-safe IFPP The program enables device makers to build a single product for every market and connect it to the Orange network before it leaves the factory. Acceleronix and IDEMIA Secure Transactions will demonstrate the solution live at electronica 2026, the international electronics trade fair, at Messe München, Hall C2, Stand 601, from 10 to 13 November. Most connected devices share the same weak spot: provisioning and testing on the pr
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 15:13:00 CET | Press release
If approved, BRUKINSA plus rituximab would be the first and only chemotherapy-free, BTK inhibitor-based regimen for adult patients with previously untreated mantle cell lymphomaApplication supported by Phase 3 MANGROVE data, showing a 43% reduction in the risk of progression or death versus bendamustine plus rituximabFull MANGROVE results to be presented during the Plenary Scientific Session at the 68th American Society of Hematology Annual Meeting BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of dis
Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 15:00:00 CET | Press release
This framework agreement provides all entities subject to the French Public Procurement Code with simplified access to a support alternative enabling them to control their costs, preserve their freedom of technological choice and free themselves from vendor-imposed upgrade cycles Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMw
Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 15:00:00 CET | Press release
New data in myeloproliferative neoplasms (MPNs) will include INCA033989, Incyte’s first-in-class, mutant calreticulin (mutCALR)-targeted monoclonal antibody, in first-line myelofibrosis (MF); and preclinical findings for Incyte’s next-generation mutCALR- and JAK2V617F-targeted compoundsUpdated results for INCA033989 in second-line MF and second-line essential thrombocythemia (ET) will build on previously presented datasetsLong-term Phase 1/2 data further characterize the potential of latarcibart (VGA039), an investigational Protein S-targeting antibody, as prophylaxis in adolescents and adults with von Willebrand disease (VWD)More than 30 abstracts will highlight progress across Incyte’s broader hematology portfolioIncyte will host an investor event and webcast on Saturday, December 12, 2026 from 7:30 – 9:00 p.m. CT (8:30 – 10:00 p.m. ET) Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstra
Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 15:00:00 CET | Press release
Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
